Nonetheless, the fact that ARDS survivors expressed higher plasma PAF-AH activity [44], combined with the fact that the prevalence of the V379 allele was lower in at least one ARDS cohort, suggests that V379 may offer some protection from this disease. This evidence concerns the gene PLA2G7 and acute respiratory distress syndrome.